Aclarion (ACON) Competitors

$0.18

-0.01 (-5.35%)

(As of 09/20/2024 ET)

ACON vs. MRAI, VSEE, CNTG, UPHL, OPGN, NIVF, BACK, GBNHF, BTTX, and AVHIW

Should you be buying Aclarion stock or one of its competitors? The main competitors of Aclarion include Marpai (MRAI), Vsee Health (VSEE), Centogene (CNTG), UpHealth (UPHL), OpGen (OPGN), NewGenIvf Group (NIVF), IMAC (BACK), Greenbrook TMS (GBNHF), Better Therapeutics (BTTX), and Achari Ventures Holdings Corp. I (AVHIW). These companies are all part of the "healthcare" industry.

Aclarion vs.

Marpai (NASDAQ:MRAI) and Aclarion (NASDAQ:ACON) are both small-cap business services companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, earnings, media sentiment, institutional ownership, community ranking and risk.

: Marpai currently has a consensus price target of $6.00, indicating a potential upside of 1,053.85%. Aclarion has a consensus price target of $1.50, indicating a potential upside of 747.46%. Given Marpai's higher probable upside, equities research analysts clearly believe Marpai is more favorable than Aclarion.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Marpai
0 Sell rating(s)
0 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
3.00
Aclarion
0 Sell rating(s)

0 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
3.00
: In the previous week, Marpai had 1 more articles in the media than Aclarion. MarketBeat recorded 1 mentions for Marpai and 0 mentions for Aclarion. Marpai's average media sentiment score of 0.00 equaled Aclarion'saverage media sentiment score.
Company Overall Sentiment
Marpai Neutral
Aclarion Neutral
: Marpai has a beta of 4.85, meaning that its share price is 385% more volatile than the S&P 500. Comparatively, Aclarion has a beta of 0.43, meaning that its share price is 57% less volatile than the S&P 500.
: Aclarion has lower revenue, but higher earnings than Marpai.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Marpai $34.87M 0.16 -$28.75M -$3.19 -0.16
Aclarion $53.95K 26.91 -$4.91M N/A N/A
: Marpai has a net margin of -92.76% compared to Aclarion's net margin of -10,967.15%. Marpai's return on equity of 0.00% beat Aclarion's return on equity.
Company Net Margins Return on Equity Return on Assets
Marpai -92.76% N/A -99.32%
Aclarion -10,967.15% -910.84% -218.13%
: 49.8% of Marpai shares are held by institutional investors. Comparatively, 7.5% of Aclarion shares are held by institutional investors. 61.3% of Marpai shares are held by insiders. Comparatively, 22.3% of Aclarion shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
: Aclarion received 1 more outperform votes than Marpai when rated by MarketBeat users. Likewise, 100.00% of users gave Aclarion an outperform vote while only 66.67% of users gave Marpai an outperform vote.
Company Underperform Outperform
Marpai Outperform Votes
2
66.67%
Underperform Votes
1
33.33%
Aclarion Outperform Votes
3
100.00%
Underperform Votes
No Votes

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Marpai	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Aclarion	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Company	Overall Sentiment
Marpai	Neutral
Aclarion	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Marpai	$34.87M	0.16	-$28.75M	-$3.19	-0.16
Aclarion	$53.95K	26.91	-$4.91M	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Marpai	-92.76%	N/A	-99.32%
Aclarion	-10,967.15%	-910.84%	-218.13%

Company	Underperform	Outperform
Marpai	Outperform Votes 2 66.67%	Underperform Votes 1 33.33%
Aclarion	Outperform Votes 3 100.00%	Underperform Votes No Votes

Summary

Marpai beats Aclarion on 9 of the 13 factors compared between the two stocks.

Ad Investors Alley

Forget Trump and Kamala

Forget Trump and Kamala. I don't care who you vote for - This calendar is the only thing that matters right now.

Download my Dividend Calendar here

Get Aclarion News Delivered to You Automatically

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ACON vs. The Competition

Export to Excel

Metric	Aclarion	Medical laboratories Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.45M	$2.54B	$5.51B	$8.43B
Dividend Yield	N/A	1.68%	4.98%	4.06%
P/E Ratio	N/A	19.60	143.04	18.91
Price / Sales	26.91	235.69	1,700.17	86.54
Price / Cash	N/A	466.30	37.43	31.50
Price / Book	-0.47	4.90	4.94	4.55
Net Income	-$4.91M	-$33.05M	$115.12M	$225.08M
7 Day Performance	-6.84%	1.47%	9.01%	3.29%
1 Month Performance	-23.77%	-1.59%	15.36%	7.78%
1 Year Performance	-97.43%	29.48%	33.07%	14.53%

Aclarion Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MRAI Marpai	1.5701 of 5 stars 1.57 / 5 stars	$0.51 flat	$6.00 +1,076.5%	-20.7%	$5.63M	$34.87M	-0.16	150
VSEE Vsee Health	0 of 5 stars 0.00 / 5 stars	$1.52 -2.6%	N/A	N/A	$5.48M	$6.38M	0.00	N/A
CNTG Centogene	0 of 5 stars 0.00 / 5 stars	$0.20 +11.1%	N/A	-79.1%	$5.42M	$48.54M	0.00	810	Gap Up
UPHL UpHealth	0 of 5 stars 0.00 / 5 stars	$0.17 flat	N/A	N/A	$3.22M	$130M	-0.13	1,750	High Trading Volume
OPGN OpGen	0 of 5 stars 0.00 / 5 stars	$2.01 -8.6%	N/A	-19.2%	$2.71M	$2.67M	0.00	100
NIVF NewGenIvf Group	0.996 of 5 stars 1.00 / 5 stars	$0.67 -4.3%	N/A	N/A	$2.60M	$5.14M	0.00	N/A	Positive News Gap Down
BACK IMAC	0 of 5 stars 0.00 / 5 stars	$1.34 +1.5%	N/A	-39.7%	$1.54M	$16.19M	0.00	180	Upcoming Earnings Gap Up
GBNHF Greenbrook TMS	0 of 5 stars 0.00 / 5 stars	$0.01 flat	N/A	N/A	$367,000.00	$73.79M	0.00	430
BTTX Better Therapeutics	0 of 5 stars 0.00 / 5 stars	N/A	N/A	N/A	$5,000.00	N/A	0.00	40
AVHIW Achari Ventures Holdings Corp. I	0 of 5 stars 0.00 / 5 stars	$0.04 flat	N/A	N/A	$0.00	N/A	0.00	3	Gap Down